Lantern Pharma Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lantern Pharma Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Lantern Pharma Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.51M, a 42.5% decline year-over-year.
  • Lantern Pharma Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$19.1M, a 26% decline year-over-year.
  • Lantern Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$16M, a 11.9% decline from 2022.
  • Lantern Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.3M, a 15.3% decline from 2021.
  • Lantern Pharma Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.4M, a 109% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$16M -$1.7M -11.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$14.3M -$1.9M -15.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$12.4M -$6.45M -109% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$5.91M -$3.48M -143% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$2.43M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.